Oxford Asset Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Oxford Asset Management’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-17,033	Closed	-$80K	–	978
2016 Q3	$80K	Sell	17,033 -60,143	-78%	-$281K	﹤0.01%	744
2016 Q2	$304K	Sell	77,176 -47,168	-38%	-$176K	0.01%	652
2016 Q1	$385K	Sell	124,344 -48,451	-28%	-$162K	0.01%	646
2015 Q4	$783K	Buy	172,795 +107,821	+166%	+$511K	0.02%	592
2015 Q3	$306K	Buy	64,974 +16,065	+33%	+$104K	0.01%	546
2015 Q2	$350K	Buy	+48,909	New	+$368K	0.01%	553
2014 Q2	–	Sell	-24,270	Closed	-$308K	–	907
2014 Q1	$308K	Buy	+24,270	New	+$314K	0.01%	564

Other funds holding DSCI

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Oxford Asset Management's DSCI Position: Q4 2016 in Review

Oxford Asset Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q4 2016, closing a stake of 17,033 shares — an estimated $80K sold.

Oxford Asset Management first reported a position in DSCI in Q1 2014 and held it in 7 quarters. The position peaked at $783K in Q4 2015. 52 funds tracked by Wall St. Rank hold DSCI as of Q4 2016.

Oxford Asset Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q4 2016 after selling out during the quarter.
Oxford Asset Management sold 17,033 Derma Sciences, Inc. Common Stock (DE) shares in Q4 2016, an estimated $80K.
Oxford Asset Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q1 2014 and held it in 7 quarters.
Oxford Asset Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $783K in Q4 2015.
52 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2016.

Based on Oxford Asset Management's 13F filing for Q4 2016, filed 9 Feb 2017.